172@29@16@22!~!172@29@0@53!~!|commonstore|commonfiles|moneycontrol_header.php?cid=2&s_cid=0&radar_off=1&is_revamped_header=1&is_responsive=1&sec=&priceinter=0&frommc=1!~!|commonstore|commonfiles|moneycontrol_header.php
Moneycontrol
you are here:

Nippon India Pharma Fund - Direct Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic

Scheme Objective

To generate consistent returns by investing in equity,equity related of fixed income securities of Pharma and other associated companies.

Scheme Details

  • Fund manager(s)Sailesh Raj Bhan
  • Launch date – 02-Jan-2013
  • Expense ratio – 1.35% as declared on 30-Jun-2020 (category average is 1.38%)
  • Benchmark - S&P BSE Healthcare TRI
  • Min SIP amount - ₹
  • Min investment amount (one time- first time) - ₹
  • Min investment amount (addtional purchase) - ₹
  • Type : Open Ended Fund. You can invest any time in this fund.

Exit Load

Nippon India Pharma Fund - Direct Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges.

Net Buy Price
Buy Date
Sell Date
  • Gross Profit
  • Exit Charges
  • Net Profit

Tax Rate

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.|If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.

Contact Details

Nippon Life India Asset Management Limited
Registered Office: Reliance Centre, 7th Floor South Wing, Off Western Express Highway, Santacruz(E) Mumbai-400055
Tel no.: 022-33031000/Touchbase30301111
Fax no.: 022-33037662
Website.: www.nipponindiamf.com

Forum

+ See More